188 related articles for article (PubMed ID: 31661724)
1. Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis.
Tada T; Kumada T; Toyoda H; Yasuda S; Sone Y; Hashinokuchi S; Ogawa S; Oguri T; Kamiyama N; Chuma M; Akita T; Tanaka J
Hepatol Res; 2020 Feb; 50(2):190-198. PubMed ID: 31661724
[TBL] [Abstract][Full Text] [Related]
2. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
Tada T; Kumada T; Toyoda H; Kobayashi N; Sone Y; Oguri T; Kamiyama N
AJR Am J Roentgenol; 2019 Feb; 212(2):332-341. PubMed ID: 30476453
[TBL] [Abstract][Full Text] [Related]
3. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
[TBL] [Abstract][Full Text] [Related]
4. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
Kumada T; Toyoda H; Yasuda S; Ogawa S; Gotoh T; Ito T; Tada T; Tanaka J
AJR Am J Roentgenol; 2022 Oct; 219(4):604-612. PubMed ID: 35506556
[No Abstract] [Full Text] [Related]
5. Intra-individual Comparisons of the Ultrasound-Guided Attenuation Parameter and the Magnetic Resonance Imaging-Based Proton Density Fat Fraction Using Bias and Precision Statistics.
Kumada T; Ogawa S; Goto T; Toyoda H; Yasuda S; Ito T; Yasuda E; Akita T; Tanaka J
Ultrasound Med Biol; 2022 Aug; 48(8):1537-1546. PubMed ID: 35613974
[TBL] [Abstract][Full Text] [Related]
6. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
Chen J; Allen AM; Therneau TM; Chen J; Li J; Hoodeshenas S; Chen J; Lu X; Zhu Z; Venkatesh SK; Song B; Ehman RL; Yin M
Eur Radiol; 2022 Feb; 32(2):950-958. PubMed ID: 34432123
[TBL] [Abstract][Full Text] [Related]
7. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease.
Ahn JH; Yu JS; Park KS; Kang SH; Huh JH; Chang JS; Lee JH; Kim MY; Nickel MD; Kannengiesser S; Kim JY; Koh SB
Magn Reson Imaging; 2021 Jul; 80():1-8. PubMed ID: 33798658
[TBL] [Abstract][Full Text] [Related]
8. Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis.
Kumada T; Toyoda H; Ogawa S; Gotoh T; Suzuki Y; Imajo K; Sugimoto K; Kakegawa T; Kuroda H; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Akita T; Tanaka J; Nakajima A
Ultrasonography; 2024 Mar; 43(2):121-131. PubMed ID: 38316132
[TBL] [Abstract][Full Text] [Related]
9. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
Kang KA; Lee SR; Jun DW; Do IG; Kim MS
Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Ultrasound Assessment of Hepatic Steatosis.
Kaliaev A; Chavez W; Soto J; Huda F; Xie H; Nguyen M; Shamdasani V; Anderson S
J Clin Exp Hepatol; 2022; 12(4):1091-1101. PubMed ID: 35814521
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
15. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
[TBL] [Abstract][Full Text] [Related]
19. Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children.
Shin HJ; Yoon H; Kim MJ; Han SJ; Koh H; Kim S; Lee MJ
World J Gastroenterol; 2018 Jul; 24(27):3013-3020. PubMed ID: 30038468
[TBL] [Abstract][Full Text] [Related]
20. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
